ENTRY       D02115                      Drug
NAME        Methotrexate sodium;
            Trexall (TN);
            Rasuvo (TN)
PRODUCT     METHOTREXATE (Hospira)
            METHOTREXATE (Hospira)
            METHOTREXATE (Hospira)
            RASUVO (Medexus Pharma)
  GENERIC   METHOTREXATE (A-S Medication Solutions)
            METHOTREXATE (A-S Medication Solutions)
            METHOTREXATE (Accord Healthcare)
            METHOTREXATE (Alvogen)
            METHOTREXATE (Amneal Pharmaceuticals NY LLC)
            METHOTREXATE (Aurobindo Pharma Limited)
            METHOTREXATE (AvKARE)
            METHOTREXATE (AvPAK)
            METHOTREXATE (Bryant Ranch Prepack)
            METHOTREXATE (Bryant Ranch Prepack)
            METHOTREXATE (Bryant Ranch Prepack)
            METHOTREXATE (Chartwell RX)
            METHOTREXATE (Fresenius Kabi USA)
            METHOTREXATE (Fresenius Kabi USA)
            METHOTREXATE (Golden State Medical Supply)
            METHOTREXATE (Major Pharmaceuticals)
            METHOTREXATE (Mylan Institutional)
            METHOTREXATE (Mylan Pharmaceuticals)
            METHOTREXATE (REMEDYREPACK)
            METHOTREXATE (REMEDYREPACK)
            METHOTREXATE (REMEDYREPACK)
            METHOTREXATE (REMEDYREPACK)
            METHOTREXATE (Sun Pharmaceutical Industries)
            METHOTREXATE (Teva Parenteral Medicines)
            METHOTREXATE (Teva Parenteral Medicines)
            METHOTREXATE (Teva Pharmaceuticals USA)
            METHOTREXATE (Zydus Lifesciences Limited)
            METHOTREXATE (Zydus Pharmaceuticals USA)
            METHOTREXATE SODIUM (Hikma Pharmaceuticals USA)
            TREXALL (Teva Women's Health)
FORMULA     C20H21N8O5. Na
EXACT_MASS  476.1533
MOL_WEIGHT  476.4211
CLASS       Antineoplastic
             DG02018  Antimetabolite
              DG01978  Folic acid analog
               DG01930  Dihydrofolate reductase inhibitor
            Anti-inflammatory
             DG01985  Disease modifying anti-rheumatic drug (DMARD)
REMARK      ATC code: L01BA01 L04AX03
            Chemical structure group: DG00681
            Product (DG00681): D00142<JP/US> D02115<US>
EFFICACY    Antineoplastic, Antimetabolite
  DISEASE   Choriocarcinoma [DS:H00028]
            Breast cancer [DS:H00031]
            Epidermoid cancers of the head and neck [DS:H02420]
            Mycosis fungoides [DS:H01463]
            Lung cancer [DS:H00013 H00014]
            Non-Hodgkin's lymphomas [DS:H02418]
            Psoriasis [DS:H01656]
            Rheumatoid arthritis [DS:H00630]
            Juvenile rheumatoid arthritis [DS:H01672]
TARGET      DHFR [HSA:1719 200895] [KO:K00287]
  PATHWAY   hsa00670(1719+200895)  One carbon pool by folate
            hsa00790(1719+200895)  Folate biosynthesis
INTERACTION  
STR_MAP     map07041  Antineoplastics - antimetabolic agents
            map07046  Immunosuppressive agents
            map07050  Antirheumatics - DMARDs and biological agents
OTHER_MAP   map04976  Bile secretion
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01B ANTIMETABOLITES
                L01BA Folic acid analogues
                 L01BA01 Methotrexate
                  D02115  Methotrexate sodium &lt;US&gt;
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AX Other immunosuppressants
                 L04AX03 Methotrexate
                  D02115  Methotrexate sodium &lt;US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Antimetabolites
               Methotrexate
                D02115  Methotrexate sodium
             Immunological Agents
              Immunosuppressants
               Antimetabolites, Antiproliferative
                Methotrexate
                 D02115  Methotrexate sodium
            Drug groups [BR:br08330]
             Antineoplastic
              DG02018  Antimetabolite
               DG01978  Folic acid analog
                DG01930  Dihydrofolate reductase inhibitor
                 DG00681  Methotrexate
                  D02115  Methotrexate sodium
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG00681  Methotrexate
                D02115  Methotrexate sodium
            Drug classes [BR:br08332]
             Antineoplastic
              DG02018  Antimetabolite
               D02115  Methotrexate sodium
             Antirheumatic agent
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               D02115  Methotrexate sodium
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Dihydrofolate reductase
                DHFR
                 D02115  Methotrexate sodium &lt;US&gt;
            Drug groups [BR:br08330]
             Antineoplastic
              DG02018  Antimetabolite
               DG01978  Folic acid analog
                DG01930  Dihydrofolate reductase inhibitor
                 DG00681  Methotrexate
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG00681  Methotrexate
DBLINKS     CAS: 15475-56-6
            PubChem: 7849176
            LigandBox: D02115
            NIKKAJI: J399.785E
ATOM        34
            1   C8y C    23.0300  -14.3500
            2   N5x N    23.0300  -15.7500
            3   C8y C    24.2900  -16.4500
            4   C8y C    25.4800  -15.7500
            5   C8y C    25.4800  -14.3500
            6   N5x N    24.2900  -13.6500
            7   N5x N    26.7400  -16.4500
            8   C8y C    27.9300  -15.7500
            9   C8x C    27.9300  -14.3500
            10  N5x N    26.7400  -13.6500
            11  N1a N    21.8400  -13.6500
            12  N1a N    24.2900  -17.8500
            13  C1b C    29.1200  -16.4500
            14  N1c N    30.3100  -15.7500
            15  C8y C    31.5000  -16.4500
            16  C1a C    30.3100  -14.3500
            17  C8x C    31.5000  -17.8500
            18  C8x C    32.7600  -18.5500
            19  C8y C    33.9500  -17.8500
            20  C8x C    33.9500  -16.4500
            21  C8x C    32.7600  -15.7500
            22  C5a C    35.1400  -18.5500
            23  N1b N    36.4000  -17.8500
            24  O5a O    35.1400  -19.9500
            25  C1c C    37.5900  -18.5500
            26  C1b C    38.7800  -17.8500
            27  C1b C    39.9700  -18.5500
            28  C6a C    41.1600  -17.8500
            29  O6a O    42.3500  -18.5500 #-
            30  C6a C    37.5900  -19.9500
            31  O6a O    38.7800  -20.6500
            32  O6a O    36.3300  -20.6500
            33  O6a O    41.1600  -16.4500
            34  Z   Na   43.9600  -18.6200 #+
BOND        35
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 2
            9     8   9 1
            10    9  10 2
            11    5  10 1
            12    1  11 1
            13    3  12 1
            14    8  13 1
            15   13  14 1
            16   14  15 1
            17   14  16 1
            18   15  17 2
            19   17  18 1
            20   18  19 2
            21   19  20 1
            22   20  21 2
            23   15  21 1
            24   19  22 1
            25   22  23 1
            26   22  24 2
            27   23  25 1
            28   25  26 1
            29   26  27 1
            30   27  28 1
            31   28  29 1
            32   25  30 1 #Up
            33   30  31 1
            34   30  32 2
            35   28  33 2
///
